MA32192B1 - Composés dérivés d'azétidines, leur préparation et leur application en thérapeutique - Google Patents
Composés dérivés d'azétidines, leur préparation et leur application en thérapeutiqueInfo
- Publication number
- MA32192B1 MA32192B1 MA33175A MA33175A MA32192B1 MA 32192 B1 MA32192 B1 MA 32192B1 MA 33175 A MA33175 A MA 33175A MA 33175 A MA33175 A MA 33175A MA 32192 B1 MA32192 B1 MA 32192B1
- Authority
- MA
- Morocco
- Prior art keywords
- group
- alkyl
- halo
- groups
- coxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
Composés répondant à la formule (i) dans laquelle : r représente un groupe (c1-c6)alkyle, un groupe halo(c1-c6)alkyle; r1 représente un atome d'hydrogène, un groupe (c1-c6)alkyle; r2 représente un groupe (c1-c6)alkyle substitué par un ou plusieurs groupes choisis parmi le groupe hydroxy, le groupe (c1-c6)alcoxy et éventuellement substitué par un groupe halo(c1-c6)alkyle; groupe hétérocycle éventuellement substitué par un ou plusieurs hydroxy, un groupe (c1-c6)alcoxy, un groupe hydroxy(c1-c6)alkyle; groupe hétérocycle(c1-c6)alkyle éventuellement substitué par un ou plusieurs hydroxy; r3 et r4 représentent chacun un groupe phényle, éventuellement substitué par un ou plusieurs atomes ou groupes choisis parmi un atome d'hydrogène, un halogène, un groupe (c1-c6)alkyle, un groupe halo(c1-c6)alkyle, un groupe (c1-c6)alcoxy, un groupe halo(c1-c6)alcoxy ou cyano; y représente un atome d'hydrogène, un halogène, un groupe (c1-c6)alkyle, un groupe halo(c1-c6)alkyle, un groupe (c1-c6)alcoxy, un groupe halo(c1-c6)alcoxy, un groupe (c1-c6)alkyls(o)p ou cyano; p est compris entre o et 2; à l'état de base ou de sel d'addition à un acide. Procédé de préparation et application en thérapeutique.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0801117A FR2928149B1 (fr) | 2008-02-29 | 2008-02-29 | Composes derives d'azetidines, leur preparation et leur application en therapeutique |
PCT/FR2009/000214 WO2009118473A2 (fr) | 2008-02-29 | 2009-02-27 | Composés dérivés d'azétidines, leur préparation et leur application en thérapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
MA32192B1 true MA32192B1 (fr) | 2011-04-01 |
Family
ID=39745128
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA33175A MA32192B1 (fr) | 2008-02-29 | 2010-09-13 | Composés dérivés d'azétidines, leur préparation et leur application en thérapeutique |
Country Status (20)
Country | Link |
---|---|
US (1) | US20110053908A1 (fr) |
EP (1) | EP2254862A2 (fr) |
JP (1) | JP2011513285A (fr) |
KR (1) | KR20100122489A (fr) |
CN (1) | CN101959855A (fr) |
AR (1) | AR070485A1 (fr) |
AU (1) | AU2009229026A1 (fr) |
BR (1) | BRPI0908336A2 (fr) |
CA (1) | CA2716961A1 (fr) |
CL (1) | CL2009000464A1 (fr) |
CO (1) | CO6251235A2 (fr) |
EA (1) | EA201071012A1 (fr) |
FR (1) | FR2928149B1 (fr) |
IL (1) | IL207799A0 (fr) |
MA (1) | MA32192B1 (fr) |
MX (1) | MX2010009512A (fr) |
PE (1) | PE20091431A1 (fr) |
TW (1) | TW200940503A (fr) |
UY (1) | UY31682A1 (fr) |
WO (1) | WO2009118473A2 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2934995B1 (fr) * | 2008-08-14 | 2010-08-27 | Sanofi Aventis | Composes d'azetidines polysubstitues, leur preparation et leur application en therapeutique |
WO2011107494A1 (fr) | 2010-03-03 | 2011-09-09 | Sanofi | Nouveaux dérivés aromatiques de glycoside, médicaments contenants ces composés, et leur utilisation |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
WO2013037390A1 (fr) | 2011-09-12 | 2013-03-21 | Sanofi | Dérivés amides d'acide 6-(4-hydroxyphényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase |
EP2760862B1 (fr) | 2011-09-27 | 2015-10-21 | Sanofi | Dérivés d'amide d'acide 6-(4-hydroxyphényl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique utilisés comme inhibiteurs de kinase |
KR101426408B1 (ko) * | 2013-02-19 | 2014-08-07 | 한국과학기술연구원 | 4각 고리 질소 화합물, 이를 포함하는 우울증, 정신 질환, 조루증, 또는 신경병증성 통증의 예방 또는 치료용 약학 조성물, 및 상기 약학 조성물을 포함하는 제제 |
GB201321601D0 (en) * | 2013-12-06 | 2014-01-22 | Canbex Therapeutics Ltd | Modulator |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6355631B1 (en) * | 2000-03-03 | 2002-03-12 | Aventis Pharma S.A. | Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation |
FR2805817B1 (fr) * | 2000-03-03 | 2002-04-26 | Aventis Pharma Sa | Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation |
US6566356B2 (en) * | 2000-03-03 | 2003-05-20 | Aventis Pharma S.A. | Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation |
US6479479B2 (en) * | 2000-03-03 | 2002-11-12 | Aventis Pharma S.A. | Azetidine derivatives, their preparation and pharmaceutical compositions containing them |
US20030139386A1 (en) * | 2001-12-21 | 2003-07-24 | Sophie Cote | Pharmaceutical compositions based on azetidine derivatives |
FR2833842B1 (fr) | 2001-12-21 | 2004-02-13 | Aventis Pharma Sa | Compositions pharmaceutiques a base de derives d'azetidine |
RU2006133258A (ru) * | 2004-02-17 | 2008-04-10 | Лабораториос Дель Др. Эстеве С.А. (Es) | Замещенные азетидиновые производные, их получение и применение в качестве лекарственных средств |
-
2008
- 2008-02-29 FR FR0801117A patent/FR2928149B1/fr not_active Expired - Fee Related
-
2009
- 2009-02-26 AR ARP090100656A patent/AR070485A1/es unknown
- 2009-02-26 PE PE2009000286A patent/PE20091431A1/es not_active Application Discontinuation
- 2009-02-26 TW TW098106237A patent/TW200940503A/zh unknown
- 2009-02-27 CL CL2009000464A patent/CL2009000464A1/es unknown
- 2009-02-27 AU AU2009229026A patent/AU2009229026A1/en not_active Abandoned
- 2009-02-27 EA EA201071012A patent/EA201071012A1/ru unknown
- 2009-02-27 CA CA2716961A patent/CA2716961A1/fr not_active Abandoned
- 2009-02-27 MX MX2010009512A patent/MX2010009512A/es not_active Application Discontinuation
- 2009-02-27 KR KR1020107019131A patent/KR20100122489A/ko not_active Application Discontinuation
- 2009-02-27 EP EP09724410A patent/EP2254862A2/fr not_active Withdrawn
- 2009-02-27 CN CN2009801069919A patent/CN101959855A/zh active Pending
- 2009-02-27 UY UY031682A patent/UY31682A1/es not_active Application Discontinuation
- 2009-02-27 BR BRPI0908336-7A patent/BRPI0908336A2/pt not_active IP Right Cessation
- 2009-02-27 WO PCT/FR2009/000214 patent/WO2009118473A2/fr active Application Filing
- 2009-02-27 JP JP2010548143A patent/JP2011513285A/ja not_active Withdrawn
-
2010
- 2010-08-19 CO CO10102306A patent/CO6251235A2/es not_active Application Discontinuation
- 2010-08-25 IL IL207799A patent/IL207799A0/en unknown
- 2010-08-26 US US12/869,281 patent/US20110053908A1/en not_active Abandoned
- 2010-09-13 MA MA33175A patent/MA32192B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
US20110053908A1 (en) | 2011-03-03 |
CN101959855A (zh) | 2011-01-26 |
CL2009000464A1 (es) | 2010-04-09 |
FR2928149A1 (fr) | 2009-09-04 |
CO6251235A2 (es) | 2011-02-21 |
PE20091431A1 (es) | 2009-10-19 |
AU2009229026A1 (en) | 2009-10-01 |
CA2716961A1 (fr) | 2009-10-01 |
EP2254862A2 (fr) | 2010-12-01 |
JP2011513285A (ja) | 2011-04-28 |
MX2010009512A (es) | 2010-12-15 |
BRPI0908336A2 (pt) | 2015-08-04 |
UY31682A1 (es) | 2009-09-30 |
AR070485A1 (es) | 2010-04-07 |
EA201071012A1 (ru) | 2011-04-29 |
IL207799A0 (en) | 2010-12-30 |
TW200940503A (en) | 2009-10-01 |
KR20100122489A (ko) | 2010-11-22 |
FR2928149B1 (fr) | 2011-01-14 |
WO2009118473A3 (fr) | 2009-11-19 |
WO2009118473A2 (fr) | 2009-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA32192B1 (fr) | Composés dérivés d'azétidines, leur préparation et leur application en thérapeutique | |
EA201101089A1 (ru) | Производные оксадиазола в качестве агонистов рецептора s1p1 | |
EA200701176A1 (ru) | Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их | |
MA32246B1 (fr) | Dérivés polysubstitues de 2-aryl-6-phenyl-imidazo[1,2- a]pyridines, leur préparation et leur application en thérapeutique | |
MY177250A (en) | Novel nicotinamide derivative or salt thereof | |
MA32247B1 (fr) | Derives de 2-aryl-6-phenyl-imidazo[1,2-a]pyridines polysubstitues, leur préparation et leur application en thérapeutique | |
MY168201A (en) | Agricultural And Horticultural Fungicidal Composition | |
EA201170096A1 (ru) | Замещенные производные пиримидона | |
ATE507208T1 (de) | Pyrimidin-verbindungen und diese enthaltende zusammensetzungen zur schädlingsbekämpfung | |
DK2123271T3 (da) | Lægemiddel til behandling af influenza | |
EP2597088A4 (fr) | Antagoniste des récepteurs p2x4 | |
WO2008108378A3 (fr) | Dérivé bicyclique d'oxomorpholine | |
TW201129564A (en) | Diphenylpyrazolopyridine derivatives, preparation thereof and therapeutic use thereof | |
UA109525C2 (xx) | Алкіламідна сполука і її застосування | |
PH12015501098A1 (en) | Antituberculous composition comprising oxazole compounds | |
EA201001087A1 (ru) | Новые дигидроиндолоновые соединения, способ их получения и фармацевтические композиции, содержащие их | |
MX2013012978A (es) | Metodo para promover el crecimiento de plantas. | |
EA200801366A1 (ru) | Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина | |
MX2009008772A (es) | Derivado piridil-triazolopirimidina o su sal, pesticida que lo contiene y proceso para su produccion. | |
CY1111748T1 (el) | Παραγωγα 7-αλκυνυλο-1.8-ναφθυριδονων, η παρασκευη τους και η εφαρμογη τους στη θεραπευτικη | |
EA200501530A1 (ru) | Новые соединения бензотиадиазина, способ их получения и фармацевтические композиции, которые их содержат | |
EA201170097A1 (ru) | Замещенные трициклические производные против нейродегенеративных заболеваний | |
BR0208812A (pt) | Derivados fenil heterociclil éter como inibidores de recaptação de serotonina | |
UA111950C2 (uk) | Гетероциклічні сполуки для лікування або профілактики розладів, викликаних зниженою нейротрансмісією серотоніну, норепінефрину або допаміну | |
TW200700419A (en) | 5,6-dialkyl-7-aminoazolopyrimidines, their preparation and their use for controlling harmful fungi, and compositions comprising these compounds |